Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Luis Perez de Llano, Elsa Naval, Natalia Mejía & Javier Domínguez-Ortega. (2022) Inhaled indacaterol/glycopyrronium/mometasone furoate fixed-dose combination in moderate-to-severe asthma. Expert Review of Respiratory Medicine 16:1, pages 1-15.
Read now
Read now
Kai Michael Beeh, Anne-Marie Kirsten, Ana-Maria Tanase, Alexia Richard, Weihua Cao, Bettina Hederer, Jutta Beier, Oliver Kornmann & Richard N van Zyl-Smit. (2018) Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3923-3936.
Read now
Read now
May Hagiwara, Thomas E. Delea & Richard H. Stanford. (2013) Risk of Asthma Exacerbation, Asthma-Related Health Care Utilization and Costs, and Adherence to Controller Therapy in Patients with Asthma Receiving Fluticasone Propionate/Salmeterol Inhalation Powder 100 μg/50 μg Versus Mometasone Furoate Inhalation Powder. Journal of Asthma 50:3, pages 287-295.
Read now
Read now
Jorge F. Maspero, Hendrik Nolte & Iván Chérrez-Ojeda. (2010) Long-Term Safety of Mometasone Furoate/Formoterol Combination for Treatment of Patients with Persistent Asthma. Journal of Asthma 47:10, pages 1106-1115.
Read now
Read now
Articles from other publishers (7)
Richard N van Zyl-Smit, Matthias Krüll, Christian Gessner, Yasuhiro Gon, Oliver Noga, Alexia Richard, Amy de los Reyes, Xu Shu, Abhijit Pethe, Ana-Maria Tanase & Peter D'Andrea. (2020) Once-daily mometasone plus indacaterol versus mometasone or twice-daily fluticasone plus salmeterol in patients with inadequately controlled asthma (PALLADIUM): a randomised, double-blind, triple-dummy, controlled phase 3 study. The Lancet Respiratory Medicine 8:10, pages 987-999.
Crossref
Crossref
Krishnendu Mondal, Rupam Kumar T. A, Pronoy Sen & Raghul Raj S.. (2020) Comparative, Prospective Study Regarding Efficacy, Safety & Adverse Effects of Anti-Asthmatic Drugs in Case of Mild to Moderate Chronic Stable Persistent Bronchial Asthma in Adults. Journal of Evolution of Medical and Dental Sciences 9:06, pages 347-352.
Crossref
Crossref
Dau Xuan Duc. (2019) Recent Progress in the Synthesis of Furan. Mini-Reviews in Organic Chemistry 16:5, pages 422-452.
Crossref
Crossref
Lev Ruzer & Naomi HarleyStephen Marek, Hugh Smyth, Lucila Garcia-Contreras, Daniel Cooney, Robert Garmise, Latarsha Jones & Anthony Hickey. 2012. Aerosols Handbook. Aerosols Handbook
1
30
.
Jeffrey A. Kohn, Kirti Deshpande & Eric A. Ortlund. (2012) Deciphering Modern Glucocorticoid Cross-pharmacology Using Ancestral Corticosteroid Receptors. Journal of Biological Chemistry 287:20, pages 16267-16275.
Crossref
Crossref
KAZUYOSHI KURASHIMA, NAHO KAGIYAMA, NOBORU TAKAYANAGI & YUTAKA SUGITA. (2011) Comparison of high-dose salmeterol/fluticasone and moderate-dose salmeterol/fluticasone plus low-dose mometasone in patients with severe persistent asthma. Respirology 16:5, pages 784-789.
Crossref
Crossref
Jason Cunningham, Kaninika Basu, Roger Tavendale, Colin N.A. Palmer, Helen Smith & Somnath Mukhopadhyay. (2011) The CHI3L1 rs4950928 polymorphism is associated with asthma-related hospital admissions in children and young adults. Annals of Allergy, Asthma & Immunology 106:5, pages 381-386.
Crossref
Crossref